BioPharma Dive 2025-12-18 Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial
Endpoints News 2025-12-18 After year of triumph, Insmed stumbles with chronic rhinosinusitis fail, brings in new asset
Illumina 2025-12-18 The Illumina-Myome Partnership That Could Save $200 Billion in U.S. Healthcare - Inside Precision Medicine
BioPharma Dive 2025-12-18 Insmed’s ‘win streak’ ends as top drug fails study in chronic nasal condition
FierceBiotech 2025-12-18 Takeda looks to 2026 FDA filing for its Sotyktu rival zasocitinib after phase 3 success
FierceBiotech 2025-12-18 After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3